Archive | Pharma Business RSS feed for this archive

FDA Warning Letter Highlights Disconnect Between Regulator & Biotech Industry

A surprise at this year’s Thanksgiving dinner was that a majority of my friends (who do not work in biopharma) at the dinner table heard about the FDA warning letter issued to 23 & Me, a biotechnology company that offers a direct-to-consumer genome test kit. Almost all of them have used the kit and find […]

Leave a Comment Continue Reading →

Staying Relevant in the Ever-changing Healthcare World: A Case of Cancer Research

What is so fascinating about today’s business world is that technologies have generated ubiquitous connectivity we have never seen before. The subsequent competition and interdependence among companies across industries have created brand-new business functions and partnerships. Who would think that the rising of technology companies like Google, Facebook and Salesforce would one day lead to […]

Leave a Comment Continue Reading →

How Online Forums Can Help Patient-Centered Drug Development: Why Should We Treat Patient-generated Online Content Seriously

In the August issue of New England Journal of Medicine (NEJM), Dr. Ethan Basch, an oncologist at Memorial Sloan-Kettering Cancer Center wrote an article titled Toward Patient-Centered Drug Development in Oncology. Dr. Basch pointed out there is a lack of patient perspective in oncology drug development—when asked about symptom information of a treatment by patients, […]

1 Comment Continue Reading →

Venture capital indicates trends of digital health

The pharmaceutical industry has been experiencing some fundamental changes–outstanding efficacy and cost-effectiveness is more essential than ever for a drug to gain market access; the traditional one-size-fits-all blockbuster strategy has been increasingly challenged by personalized medicine, and the use of medicine is declining. These changes suggest the pharmaceutical industry needs to transform from “drug maker” to […]

2 Comments Continue Reading →

Demonstrating the value of mobile health Through evidence-based initiatives

Earlier this week,  the pharma company Boehringer Ingelheim launched a study to evaluate a digital technology enabled self-management solution to potentially improve the health of patients with Type 2 diabetes. The study, called SMART, aims to personalize the disease management for patients via a program delivered through web and smartphone. According to a press release, the […]

Leave a Comment Continue Reading →